Direkt zum Inhalt
Merck

GC Analysis of Amphetamine Enantiomers (N-Trifluoroacetyl Derivatives) on Astec® CHIRALDEX G-DP

GC Analysis of Amphetamine Enantiomers (N-Trifluoroacetyl Derivatives) on Astec® CHIRALDEX™ G-DP suitable for GC

Materialien

Analytische Säule

Produkt-Nr.
Beschreibung
Preisangaben

Astec® CHIRALDEX G-DP Capillary GC Column

L × I.D. 30 m × 0.25 mm, df 0.12 μm

Anwendung

Produkt-Nr.
Beschreibung
Preisangaben

GC Analysis of Amphetamine Enantiomers (N-Trifluoroacetyl Derivative) on Astec® CHIRALDEX G-PN

suitable for GC

Standard

Produkt-Nr.
Beschreibung
Preisangaben

D-Amphetamin -hemisulfat (Salz) -Lösung

1.0 mg/mL in methanol, analytical standard, for drug analysis

DL-Amphetamin -sulfat (Salz)

D-Amphetamin -sulfat (Salz)

DL-Amphetamin -hydrochlorid

analytical standard

CONDITIONS

column

Astec CHIRALDEX G-DP, 30 m x 0.25 mm I.D., 0.12 μm (78033AST)

oven

140 °C

detector

FID, 250 °C

inj. temp.

250 °C

carrier gas

helium, 2.7 mL/min., constant flow

injection

1 μL, 80:1 split

liner

4 mm I.D., FocusLiner

sample

4 mg/mL each compound in methylene chloride
peak 1: d-amphetamine (N-TFA derivative)
peak 2: l-amphetamine (N-TFA derivative)

Beschreibung

Hinweis zur Analyse

Elution order reversal (l,d) by using CHIRALDEX G-PN, 130°C (see G005053).

Rechtliche Hinweise

Astec is a registered trademark of Merck KGaA, Darmstadt, Germany
CHIRALDEX is a trademark of Sigma-Aldrich Co. LLC